Crossmark Global Holdings, Inc. Verona Pharma PLC Transaction History
Crossmark Global Holdings, Inc.
- $5.49 Billion
- Q4 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 16,245 shares of VRNA stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,245
Previous 16,150
0.59%
Holding current value
$1.05 Million
Previous $465,000
62.15%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$413 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$361 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$219 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$202 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$202 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.94B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...